BACKGROUND: The DRAGON score, which includes clinical and computed tomographic (CT) scan parameters, predicts functional outcomes in ischemic stroke patients treated with intravenous tissue plasminogen activator (IV tPA). We assessed the utility of the DRAGON score in predicting functional outcome in stroke patients receiving both IV tPA and endovascular therapy. METHODS: A retrospective chart review of patients treated at our institution from February 2009 to October 2015 was conducted. All patients with computed tomography angiography (CTA) proven large vessel occlusions (LVO) who underwent intravenous thrombolysis and endovascular therapy were included. Baseline DRAGON scores and modified Rankin Score (mRS) at the time of hospital discharge was calculated. Good outcome was defined as mRS /=7 was associated with higher mRS (P < 0.006) and higher mortality (P < 0.0001) compared with DRAGON scores
Wang, A., Pednekar, N., Lehrer, R., Todo, A., Sahni, R., Marks, S., & Stiefel, M. (2017). DRAGON Score Predicts Functional Outcomes in Acute Ischemic Stroke Patients Receiving Both Intravenous Tissue Plasminogen Activator and Endovascular Therapy. Surgical Neurology International, 8, 149. https://doi.org/10.4103/2152-7806.210993
Originally published in Surgical Neurology International 2017;8:149. The original material can be found here.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.